Maximum quantity allowed is 999
CAS RN: 848695-25-0 | Product Number: B5775
BIIB 021
Purity: >98.0%(HPLC)
- 6-Chloro-9-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-9H-purin-2-amine
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
25MG |
₹5,040.00
|
1 | 6 |
|
100MG |
₹11,520.00
|
Contact Us | 11 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | B5775 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__4H__1__5ClN__6O = 318.77 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Frozen (<0°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Air Sensitive,Heat Sensitive |
CAS RN | 848695-25-0 |
Reaxys Registry Number | 11080986 |
MDL Number | MFCD15528939 |
Appearance | White to Light yellow to Light orange powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Elemental analysis(Nitrogen) | 25.00 to 27.50 % |
Melting point | 186.0 to 190.0 °C |
NMR | confirm to structure |
Melting Point | 189 °C |
Pictogram | |
Signal Word | Warning |
Hazard Statements | H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
Precautionary Statements | P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ eye protection/ face protection. P302 + P352 : IF ON SKIN: Wash with plenty of water. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. |
References
- BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90
- BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance
- BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy
- The discovery of BIIB021 and BIIB028 (a review)
- Heat shock proteins: a potential anticancer target (a review)
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.